Peroxisome proliferator-activated receptor-gamma2-Pro12Ala and endothelial nitric oxide synthase-4a/b gene polymorphisms are associated with essential hypertension

This publication has 41 references indexed in Scilit:

• Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-γ ₂ (PPARγ ₂) is associated with higher levels of total cholesterol and LDL-cholesterol in male caucasian type 2 diabetes patients
  Experimental and Clinical Endocrinology & Diabetes, 2002
• The role of PPARγ in high-fat diet-induced obesity and insulin resistance
  Journal of Diabetes and its Complications, 2002
• Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 (PPAR-γ2) gene in relation to insulin sensitivity among glucose tolerant Caucasians
  Diabetologia, 2001
• A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity
  Acta Endocrinologica, 2001
• The ligands/activators for peroxisome proliferator-activated receptor α (PPARα) and PPARγ increase Cu2+, Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells
  Metabolism, 2001
• Guilt by association
  Nature Genetics, 2000
• Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations.
  Diabetes, 1998
• A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity
  Nature Genetics, 1998
• Molecular Scanning of the Human Peroxisome Proliferator Activated Receptor γ (hPPARγ) Gene in Diabetic Caucasians: Identification of a Pro12Ala PPARγ2 Missense Mutation
  Biochemical and Biophysical Research Communications, 1997
• The Organization, Promoter Analysis, and Expression of the Human PPARγ Gene
  Journal of Biological Chemistry, 1997